Eletriptan Hydrobromide
Product Images NDC 27241-040

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 27241-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eletriptan 20mg

This appears to be a description of a medication called Eletriptan Hydrobromide in tablet form, manufactured by Ajanta Pharma USA Inc. The tablets come in unit dose packaging and contain between 10-20 mg of Eletriptan Hydrobromide. Dosage information is not provided, but the accompanying prescribing information should clarify how to use the medication. Recommended storage temperature is between 20°C to 25°C (68°F to 77°F), but excursions between 15°C to 30°C (59°F to 86°F) are permitted.*

FDA Label Image

Eletriptan 40mg

This is a description of a medication called Eletriptan Hydrobromide, which comes in the form of unit dose tablets. The tablets are stored in a temperature range of 20°C to 25°C (68°F to 77°F), and dosing information can be found in the prescribing information that comes with the medication. Each tablet contains 40 mg of eletriptan hydrobromide. It is marketed by Ajanta Pharma USA Inc. and made in India.*

FDA Label Image

Fig_1 (Eletriptan Fig1)

The figure shows the estimated probability of initial headache response within 2 hours as a function of the dose and the time intervals. No further information is available.*

FDA Label Image

Fig_2 (Eletriptan Fig2)

FDA Label Image

Str (Eletriptan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.